MOTS-C
A mitochondrial-derived peptide studied for metabolic flexibility, exercise capacity, and how efficiently your cells produce energy.
Energy at the mitochondrial level.
MOTS-C is coded inside your mitochondria, not your nucleus. It acts as a metabolic signal — nudging cells toward glucose uptake, fat oxidation, and stress resilience rather than pushing your nervous system harder.
How it works
MOTS-C is a mitochondrial-derived peptide — a short signaling molecule encoded by mitochondrial DNA. Research suggests it activates AMPK, the same energy-sensing pathway your body uses during exercise and fasting, which influences how cells pull in glucose and burn fat for fuel.
The result isn't a jolt. It's a slow shift toward metabolic flexibility — your body getting better at switching between fuel sources instead of stalling out. Levels decline with age, which is part of why the same training stops producing the same result.
What to expect
- CadenceOne self-administered subcutaneous injection two to three times per week.
- FormatMOTS-C — a 16-amino-acid mitochondrial-derived peptide.
- ResponseMost patients describe steadier training energy within 3–6 weeks; metabolic shifts unfold over months.
- Good fit ifYou train regularly, feel your metabolic ceiling dropping, and want cellular-level support rather than a stimulant.
- Side-effect patternGenerally well tolerated. Mild injection-site redness or transient fatigue after early doses can occur.
Who it's for
MOTS-C suits adults who are already consistent with training and nutrition but feel their metabolic engine running less efficiently than it used to.
- Active adults 30+ noticing slower recovery and a flatter metabolic response.
- You want cellular energy support without a stimulant.
- You're pairing it with resistance training and adequate protein.
- Comfortable with a small at-home subcutaneous injection a few times per week.
- —Currently pregnant, planning pregnancy, or breastfeeding.
- —Active or recent malignancy without oncologist sign-off.
- —Uncontrolled diabetes or unmanaged endocrine conditions.
- —Under 18, or otherwise not appropriate on clinician review.
Your first 90 days
MOTS-C works on a metabolic timescale. Training energy tends to move first, with body composition and endurance following.
- Days 1–30Your baseline settles
You start a conservative twice-weekly dose while your clinician watches tolerance. Most patients feel nothing dramatic in the first few weeks — that's expected.
- Days 31–60Training energy steadies
Sessions feel less taxing and recovery between them shortens. Your clinician may move you to a three-times-weekly cadence depending on response.
- Days 61–90Metabolic flexibility shows up
Steadier energy between meals, better endurance, and gradual body-composition change. Your clinician reviews progress and decides whether to continue, cycle off, or stack.
